$117M venture firm takes flight in Europe
A group of Elan veterans in Ireland have launched a €75 million ($117 million) venture fund for life sciences companies. Fountain Healthcare Partners, based in Dublin, plans to sink anywhere from €500,000 to €7 million in a variety of companies in Europe, with a big focus on Ireland. And the principals expect considerable demand for the cash.
"For companies looking to raise $10 to $15 million to undertake a phase I or phase II study, they really don't have dedicated venture capital funds to raise that money," says partner Aidan King.
- see this release
- read the report in the Wall Street Journal
Be the first to comment
More stories about Aidan King Fountain Healthcare Partners Venture Capital fund Ireland Venture Capital Elan Phase II
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets